Frontier Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $16.7M | Sell |
|
|||||
|
2019
Q3 | $53.1M | Sell |
|
|||||
|
2019
Q2 | $85.5M | Sell |
|
|||||
|
2019
Q1 | $112M | Buy |
|
|||||
|
2018
Q4 | $93.7M | Buy |
|
|||||
|
2018
Q3 | $118M | Buy |
|
|||||
|
2018
Q2 | $88.8M | Buy |
|
|||||
|
2018
Q1 | $59.5M | Buy |
|
|||||
|
2017
Q4 | $67.2M | Sell |
|
|||||
|
2017
Q3 | $97.2M | Sell |
|
|||||
|
2017
Q2 | $78.4M | Sell |
|
|||||
|
2017
Q1 | $59.1M | Buy |
|
|||||
|
2016
Q4 | $50.6M | Buy |
|
|||||
|
2016
Q3 | $50M | Buy |
|
|||||
|
2016
Q2 | $56M | Sell |
|
|||||
|
2016
Q1 | $78.4M | Buy |
|
|||||
|
2015
Q4 | $86.2M | Buy |
|
|||||
|
2015
Q3 | $61.1M | Buy |
|
|||||
|
2015
Q2 | $38.6M | Buy |
|
|||||
|
2015
Q1 | $38.3M | Buy |
|
|||||
|
2014
Q4 | $34.4M | Sell |
|
|||||
|
2014
Q3 | $39.8M | Buy |
|
|||||
|
2014
Q2 | $40.1M | Buy |
|
|||||
|
2014
Q1 | $33.4M | Buy |
|
|||||
|
2013
Q4 | $11.3M | Sell |
|
|||||
|
2013
Q3 | $12.9M | Buy |
|
|||||
|
2013
Q2 | $12.7M | Buy |
|